Cargando…
Mechanistic Insights into Autoinhibition of the Oncogenic Chromatin Remodeler ALC1
Human ALC1 is an oncogene-encoded chromatin-remodeling enzyme required for DNA repair that possesses a poly(ADP-ribose) (PAR)-binding macro domain. Its engagement with PARylated PARP1 activates ALC1 at sites of DNA damage, but the underlying mechanism remains unclear. Here, we establish a dual role...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745148/ https://www.ncbi.nlm.nih.gov/pubmed/29220652 http://dx.doi.org/10.1016/j.molcel.2017.10.017 |
_version_ | 1783288865756282880 |
---|---|
author | Lehmann, Laura C. Hewitt, Graeme Aibara, Shintaro Leitner, Alexander Marklund, Emil Maslen, Sarah L. Maturi, Varun Chen, Yang van der Spoel, David Skehel, J. Mark Moustakas, Aristidis Boulton, Simon J. Deindl, Sebastian |
author_facet | Lehmann, Laura C. Hewitt, Graeme Aibara, Shintaro Leitner, Alexander Marklund, Emil Maslen, Sarah L. Maturi, Varun Chen, Yang van der Spoel, David Skehel, J. Mark Moustakas, Aristidis Boulton, Simon J. Deindl, Sebastian |
author_sort | Lehmann, Laura C. |
collection | PubMed |
description | Human ALC1 is an oncogene-encoded chromatin-remodeling enzyme required for DNA repair that possesses a poly(ADP-ribose) (PAR)-binding macro domain. Its engagement with PARylated PARP1 activates ALC1 at sites of DNA damage, but the underlying mechanism remains unclear. Here, we establish a dual role for the macro domain in autoinhibition of ALC1 ATPase activity and coupling to nucleosome mobilization. In the absence of DNA damage, an inactive conformation of the ATPase is maintained by juxtaposition of the macro domain against predominantly the C-terminal ATPase lobe through conserved electrostatic interactions. Mutations within this interface displace the macro domain, constitutively activate the ALC1 ATPase independent of PARylated PARP1, and alter the dynamics of ALC1 recruitment at DNA damage sites. Upon DNA damage, binding of PARylated PARP1 by the macro domain induces a conformational change that relieves autoinhibitory interactions with the ATPase motor, which selectively activates ALC1 remodeling upon recruitment to sites of DNA damage. |
format | Online Article Text |
id | pubmed-5745148 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Cell Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-57451482018-01-02 Mechanistic Insights into Autoinhibition of the Oncogenic Chromatin Remodeler ALC1 Lehmann, Laura C. Hewitt, Graeme Aibara, Shintaro Leitner, Alexander Marklund, Emil Maslen, Sarah L. Maturi, Varun Chen, Yang van der Spoel, David Skehel, J. Mark Moustakas, Aristidis Boulton, Simon J. Deindl, Sebastian Mol Cell Article Human ALC1 is an oncogene-encoded chromatin-remodeling enzyme required for DNA repair that possesses a poly(ADP-ribose) (PAR)-binding macro domain. Its engagement with PARylated PARP1 activates ALC1 at sites of DNA damage, but the underlying mechanism remains unclear. Here, we establish a dual role for the macro domain in autoinhibition of ALC1 ATPase activity and coupling to nucleosome mobilization. In the absence of DNA damage, an inactive conformation of the ATPase is maintained by juxtaposition of the macro domain against predominantly the C-terminal ATPase lobe through conserved electrostatic interactions. Mutations within this interface displace the macro domain, constitutively activate the ALC1 ATPase independent of PARylated PARP1, and alter the dynamics of ALC1 recruitment at DNA damage sites. Upon DNA damage, binding of PARylated PARP1 by the macro domain induces a conformational change that relieves autoinhibitory interactions with the ATPase motor, which selectively activates ALC1 remodeling upon recruitment to sites of DNA damage. Cell Press 2017-12-07 /pmc/articles/PMC5745148/ /pubmed/29220652 http://dx.doi.org/10.1016/j.molcel.2017.10.017 Text en © 2017 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lehmann, Laura C. Hewitt, Graeme Aibara, Shintaro Leitner, Alexander Marklund, Emil Maslen, Sarah L. Maturi, Varun Chen, Yang van der Spoel, David Skehel, J. Mark Moustakas, Aristidis Boulton, Simon J. Deindl, Sebastian Mechanistic Insights into Autoinhibition of the Oncogenic Chromatin Remodeler ALC1 |
title | Mechanistic Insights into Autoinhibition of the Oncogenic Chromatin Remodeler ALC1 |
title_full | Mechanistic Insights into Autoinhibition of the Oncogenic Chromatin Remodeler ALC1 |
title_fullStr | Mechanistic Insights into Autoinhibition of the Oncogenic Chromatin Remodeler ALC1 |
title_full_unstemmed | Mechanistic Insights into Autoinhibition of the Oncogenic Chromatin Remodeler ALC1 |
title_short | Mechanistic Insights into Autoinhibition of the Oncogenic Chromatin Remodeler ALC1 |
title_sort | mechanistic insights into autoinhibition of the oncogenic chromatin remodeler alc1 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745148/ https://www.ncbi.nlm.nih.gov/pubmed/29220652 http://dx.doi.org/10.1016/j.molcel.2017.10.017 |
work_keys_str_mv | AT lehmannlaurac mechanisticinsightsintoautoinhibitionoftheoncogenicchromatinremodeleralc1 AT hewittgraeme mechanisticinsightsintoautoinhibitionoftheoncogenicchromatinremodeleralc1 AT aibarashintaro mechanisticinsightsintoautoinhibitionoftheoncogenicchromatinremodeleralc1 AT leitneralexander mechanisticinsightsintoautoinhibitionoftheoncogenicchromatinremodeleralc1 AT marklundemil mechanisticinsightsintoautoinhibitionoftheoncogenicchromatinremodeleralc1 AT maslensarahl mechanisticinsightsintoautoinhibitionoftheoncogenicchromatinremodeleralc1 AT maturivarun mechanisticinsightsintoautoinhibitionoftheoncogenicchromatinremodeleralc1 AT chenyang mechanisticinsightsintoautoinhibitionoftheoncogenicchromatinremodeleralc1 AT vanderspoeldavid mechanisticinsightsintoautoinhibitionoftheoncogenicchromatinremodeleralc1 AT skeheljmark mechanisticinsightsintoautoinhibitionoftheoncogenicchromatinremodeleralc1 AT moustakasaristidis mechanisticinsightsintoautoinhibitionoftheoncogenicchromatinremodeleralc1 AT boultonsimonj mechanisticinsightsintoautoinhibitionoftheoncogenicchromatinremodeleralc1 AT deindlsebastian mechanisticinsightsintoautoinhibitionoftheoncogenicchromatinremodeleralc1 |